Literature DB >> 15467531

Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.

Jurgen M J Piek1, Peter Kenemans, René H M Verheijen.   

Abstract

OBJECTIVE: Serous ovarian, Fallopian tube, and peritoneal adenocarcinomas are remarkably similar, both in their morphology, as well as in their clinical behavior. Despite extensive clinical and fundamental research, controversy still exists on the origin of serous female adnexal tumors. Difficulties in identification of site of origin at late stage the of disease at detection, when ovary, Fallopian tube, and the abdominal cavity are usually all involved, in addition to their macroscopic and microscopic resemblance, are major causes of this debate. In 3 hypotheses, 3 possible tissues of origin are proposed: the ovarian surface epithelium, the Fallopian tube epithelium, and the secondary Mullerian system. STUDY
DESIGN: We searched for all peer-reviewed articles and reviews that examined "serous ovarian carcinoma," "Fallopian tube carcinoma," "Mullerian system," "ovarian surface epithelium," "tubal epithelium," and "peritoneal." We included only articles that could give information on the origin of serous carcinomas. Additional articles were added by examining references of overview articles in relevant fields.
RESULTS: Discussed are the experimental data underlying these hypotheses.
CONCLUSION: An attempt is made to integrate the 3 hypotheses into a comprehensive model of serous intraperitoneal adenocarcinogenesis. It can be concluded that the Fallopian tubes play a major role in the development of female serous cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467531     DOI: 10.1016/j.ajog.2004.02.067

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.

Authors:  Wa Xian; Alexander Miron; Michael Roh; Dana R Semmel; Yosuf Yassin; Judy Garber; Esther Oliva; Annekathryn Goodman; Karishma Mehra; Ross S Berkowitz; Christopher P Crum; Bradley J Quade
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 3.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

4.  A case of non-invasive serous adenocarcinoma at unilateral fimbria with spread to the peritoneal/uterine cavity: case report.

Authors:  Yuki Fukumura; Akiko Masaoka; Toshio Naito; Miki Kimura; Takashi Yao
Journal:  Diagn Pathol       Date:  2009-12-05       Impact factor: 2.644

5.  A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.

Authors:  Ann K Folkins; Elke A Jarboe; Aasia Saleemuddin; Yonghee Lee; Michael J Callahan; Ronny Drapkin; Judy E Garber; Michael G Muto; Shelley Tworoger; Christopher P Crum
Journal:  Gynecol Oncol       Date:  2008-03-14       Impact factor: 5.482

6.  Genetic analysis of the early natural history of epithelial ovarian carcinoma.

Authors:  Bhavana Pothuri; Mario M Leitao; Douglas A Levine; Agnès Viale; Adam B Olshen; Crispinita Arroyo; Faina Bogomolniy; Narciso Olvera; Oscar Lin; Robert A Soslow; Mark E Robson; Kenneth Offit; Richard R Barakat; Jeff Boyd
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

7.  Inhibitory role of prohibitin in human ovarian epithelial cancer.

Authors:  Lin Jia; Jian-Min Ren; Yi-Ying Wang; Yu Zheng; Hui Zhang; Qing Zhang; Bei-Hua Kong; Wen-Xin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 8.  Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

Authors:  Christopher P Crum; Ronny Drapkin; David Kindelberger; Fabiola Medeiros; Alexander Miron; Yonghee Lee
Journal:  Clin Med Res       Date:  2007-03

Review 9.  Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Authors:  Henry T Lynch; Murray Joseph Casey; Carrie L Snyder; Chhanda Bewtra; Jane F Lynch; Matthew Butts; Andrew K Godwin
Journal:  Mol Oncol       Date:  2009-02-21       Impact factor: 6.603

10.  Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues.

Authors:  Christina D Drenberg; Sandra Livingston; Ren Chen; Patricia A Kruk; Santo V Nicosia
Journal:  Obstet Gynecol Int       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.